Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. - Wikidata - awgldk - TriplyDB

Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade.

Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade.

http://www.wikidata.org/entity/Q34320172

about

Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist.Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases A serotonin and melanocortin circuit mediates D-fenfluramine anorexia In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism Dopamine physiology in the basal ganglia of male zebra finches during social stimulation.Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors.The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model.Innovative approaches for the development of antidepressant drugs: current and future strategies The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders 5-HT2CR blockade in the amygdala conveys analgesic efficacy to SSRIs in a rat model of arthritis pain.Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.Comparison of female Fischer and Sprague-Dawley rats in the response to ketanserin.Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.5-HT2C receptor modulators: a patent survey.5-HT2 ligands in the treatment of anxiety and depression.Treatment-resistant depression: are animal models of depression fit for purpose?Looking back (and in)to the future: A personal reflection on 'Serotonin autoreceptor function and antidepressant drug action' (Hjorth et al., 2000).A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.Serotonin2C receptors in the nucleus accumbens are involved in enhanced alcohol-drinking behavior.Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.Effect of combination of ketanserin and escitalopram on behavioral anomalies after olfactory bulbectomy: prediction of quick onset of antidepressant action.Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum.Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.Ebselen has lithium-like effects on central 5-HT2A receptor function.

P2860

Q21129279-EAE10131-F012-4407-A34D-A2E8ABD4D46A Q24684698-9811EFAE-8587-490E-9D13-13187E232325 Q28066691-BB3790A6-6F32-4E3B-A4D0-F609C52C7333 Q28506385-FF4CF788-BA81-4423-9330-31D5D91EEDEB Q28565374-78C31CC0-0FC7-46FA-9CD0-4634717F96A7 Q28610467-E3655EDA-74B0-48F3-89AC-C9DA21F7EA0D Q30487278-1378ABA6-F30C-4D5E-9E9D-5242DCFDB91F Q34158784-176EA473-813E-4A0C-B73B-8690AA5BD6CF Q34280398-C07DD6C4-9277-4B96-9ADA-67C45FA4C109 Q34971199-0FF07909-9486-4717-AFDD-09E1240B866A Q36401400-2A61573F-80D1-4CD4-A9E1-6FB71E27004F Q36917104-CE852F37-8992-4AAD-9B50-18B2959C4F55 Q37114728-A813F2DC-2754-4894-9829-FFFED42702CB Q37347736-FB0EE154-4AB0-4314-B497-83706C03EB85 Q37481197-354BF28D-588A-44C2-BE0D-F622611ECEA7 Q37515934-6112AAAF-9F1E-431E-9E82-16463060CA4B Q37776154-C2678BF2-2B1F-4151-AEA9-E1E3A0DBE6FA Q37789738-F7DFF40A-C31A-456E-976D-7C769BDEE178 Q38037141-4BFFC71B-278D-44F5-8318-0231F426337C Q38569708-110BD0EE-D951-45E9-9159-4DA852393DB3 Q38868838-ED4E570A-8FAF-48DC-9A0C-FFDF55434A7F Q39164871-F35BBD02-A4E6-46AD-8CDA-26128399D4CC Q41458899-5959C448-84F2-4E01-9619-10EEFFE60407 Q42129272-EF71966D-F0E6-4D8C-B1A9-37CBC0ECF212 Q42176392-589590C4-B760-4240-88BD-FA2D1BF5C84B Q42494096-D8DB7CE2-DAF0-46DE-80C1-EF6C9F2ED87E Q46435462-B5A8A286-FA60-4F5A-A182-3B460FA4F361 Q48319504-306F0AC1-1307-4021-8C44-3AC6E016A719 Q48402641-6F5F5899-00B6-4EFB-A87E-693E9997F17F Q53445382-2FE49336-05B5-403D-ACED-0921051E3713

P2860

Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade.

http://www.wikidata.org/entity/Q34320172

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Inactivation of 5-HT

@nl

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@ast

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@en

type

label

Inactivation of 5-HT

@nl

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@ast

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@en

prefLabel

Inactivation of 5-HT

@nl

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@ast

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@en

P1433

Q34320172-8AB08942-9C4B-47AE-B6AA-C72F789AE8D3

P1476

Q34320172-35EDD19B-A3FD-43EB-9C39-E1715BC773A2

P2093

Q34320172-01B627B2-4F40-4A24-A24D-E5D6ED5C60A4

Q34320172-3428EE7A-8BDE-4AA5-9A10-CD75C1F64716

Q34320172-3821961F-463A-4CA5-9273-819F38C1AF40

Q34320172-3C06F8B2-DF65-4228-94EB-7AF2C199702D

Q34320172-54648786-485A-4403-B54C-D92B4EAE88E9

Q34320172-77B460E2-639D-4498-B4A0-0D708F425A14

Q34320172-806248B4-D015-41EE-B477-A81BACBA0301

Q34320172-80F39FB0-E960-4B1D-90BE-7AB8AC69FC63

Q34320172-AB90E8AA-651C-4202-A6F6-C01648836C00

Q34320172-BC8E8929-4648-45DB-8665-F606DD7CBD7C

P2860

Q34320172-0E4EC15E-41AB-4ED6-B373-ECBE7B52269C

Q34320172-0EA84E72-EAE8-40D6-88BD-499419E9184C

Q34320172-23A96E1E-D09F-488A-B2EE-68159CC42259

Q34320172-2EB8A098-7080-48E6-A5B3-546B765C2A4C

Q34320172-469B6E06-467D-4E3E-B9EF-95B3E8B3E730

Q34320172-47311C43-0E1F-4462-96E9-08E3024B35CB

Q34320172-54781222-663D-49DB-9DBD-CEC70FF83344

Q34320172-5C3F3038-244B-4CD1-AA51-4BA1DC180F97

Q34320172-761C1C90-67AD-4D08-8A3B-F5B7BB8439DF

Q34320172-79419487-7C7E-4AA4-9FBA-96EC138214FD

P2888

Q34320172-9F3FB9A6-487B-406A-A4BA-7F4F1D34E881

P304

Q34320172-C818C352-97E2-4BE1-9DF1-48D56D85C0C4

P31

Q34320172-5B73E513-BD8D-44E3-8931-65BBBA7366A7

P356

Q34320172-8B8EBC03-7DBE-4103-AD4B-2878C0F53ADB

P407

Q34320172-6CA74875-2792-4697-88B1-ECD6F5DD9E8B

P433

Q34320172-FF9F0DAC-CC96-4FC7-AEB9-9FFDC523C767

P478

Q34320172-D9A59ECB-3459-4B6F-BAD9-2E73732B9529

P577

Q34320172-1ED1E50E-9D2B-43E7-BE4F-69298D9DCFE9

P5875

Q34320172-CE4ED414-E201-4AF1-BBD7-9C261D4C20FF

P6179

Q34320172-23495C9C-C01B-4355-BBF4-9EB5967349D3

P698

Q34320172-5EEDB882-D02D-4786-8B75-7B38C381A7AE

P356

P1433

Neuropsychopharmacology

P1476

Inactivation of 5-HT(2C) recep ...... f serotonin reuptake blockade.

@en

P2093

Arne Mørk

http://www.w3.org/2001/XMLSchema#string

Ben H C Westerink

http://www.w3.org/2001/XMLSchema#string

Fokko J Bosker

http://www.w3.org/2001/XMLSchema#string

Gerard Honig

http://www.w3.org/2001/XMLSchema#string

Hans den Boer

http://www.w3.org/2001/XMLSchema#string

Håkan V Wikstrom

http://www.w3.org/2001/XMLSchema#string

Jørn Arnt

http://www.w3.org/2001/XMLSchema#string

Klaus-Peter Bøgesø

http://www.w3.org/2001/XMLSchema#string

Laurence H Tecott

http://www.w3.org/2001/XMLSchema#string

Marco Giorgetti

http://www.w3.org/2001/XMLSchema#string

P2860

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy

Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats.

Animal models of depression: utility for transgenic research.

Separate systems for serotonin and leptin in appetite control.

How does pindolol improve antidepressant action?

Depression: perspectives from affective neuroscience.

P2888

P304

1782-1789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1300474

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8568411

http://www.w3.org/2001/XMLSchema#string

P6179

1052388328

http://www.w3.org/2001/XMLSchema#string

P698

15138437

http://www.w3.org/2001/XMLSchema#string